Richard Sylvester
Impact in
Papers in
- Surgery 188
- Bladder and Urothelial Cancer Treatments 158
- Urinary and Genital Oncology Studies 116
-
- Prostate Cancer Treatment and Research 35
- Renal cell carcinoma treatment 25
- Co-authors
- Adrian P.M. van der Meijden (11 shared papers)Willem Oosterlinck (21 shared papers)Marko Babjuk (20 shared papers)Morgan Rouprêt (29 shared papers)J. Alfred Witjes (21 shared papers)Andreas Böhle (19 shared papers)Bas W.G. van Rhijn (16 shared papers)Shahrokh F. Shariat (21 shared papers)
- Journals
- European Urology (61 papers)The Journal of Urology (39 papers)Journal of Clinical Oncology (23 papers)European Journal of Cancer (14 papers)Controlled Clinical Trials (11 papers)
- Partner nations
- BelgiumNetherlandsUnited Kingdom
In The Last Decade
Richard Sylvester
358 papers receiving 35.9k citations
Richard Sylvester's Hit Papers
Peers
Comparison fields: 5 of 192
- Urology 6.7k
- Surgery 24.1k
- Pulmonary and Respiratory Medicine 10.3k
- Cancer Research 4.6k
- Oncology 8.3k
Countries citing papers authored by Richard Sylvester
This map shows the geographic impact of Richard Sylvester's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard Sylvester with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard Sylvester more than expected).
Fields of papers citing papers by Richard Sylvester
This network shows the impact of papers produced by Richard Sylvester. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard Sylvester. The network helps show where Richard Sylvester may publish in the future.
Co-authors
The 25 scholars most cited alongside Richard Sylvester, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 369 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Predicting Recurrence and Progression in Individual Patients with Stage Ta T1 Bladder Cancer Using EORTC Risk Tables: A Combined Analysis of 2596 Patients from Seven EORTC Trials Hit paper breakdown → | 2006 | 2101 |
| 2 | EAU Guidelines on Non–Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016 Hit paper breakdown → | 2016 | 1546 |
| 3 | European Association of Urology Guidelines on Upper Urinary Tract Urothelial Cell Carcinoma: 2015 Update Hit paper breakdown → | 2015 | 1066 |
| 4 | Radical nephrectomy plus interferon-alfa-based immunotherapy compared with interferon alfa alone in metastatic renal-cell carcinoma: a randomised trial Hit paper breakdown → | 2001 | 1006 |
| 5 | EAU Guidelines on Non–Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2013 Hit paper breakdown → | 2013 | 927 |
| 6 | Intravesical Bacillus Calmette-Guerin Reduces the Risk of Progression in Patients with Superficial Bladder Cancer: A Meta-analysis of the Published Results of Randomized Clinical Trials Hit paper breakdown → | 2002 | 910 |
| 7 | WHO handbook for reporting results of cancer treatment Hit paper breakdown → | 1980 | 899 |
| 8 | European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (TaT1 and Carcinoma In Situ) - 2019 Update Hit paper breakdown → | 2019 | 893 |
| 9 | European Association of Urology Guidelines on Non–muscle-invasive Bladder Cancer (Ta, T1, and Carcinoma in Situ) Hit paper breakdown → | 2021 | 860 |
| 10 | EAU Guidelines on Non–Muscle-Invasive Urothelial Carcinoma of the Bladder, the 2011 Update Hit paper breakdown → | 2011 | 785 |
| 11 | A Prospective Randomized EORTC Intergroup Phase 3 Study Comparing the Complications of Elective Nephron-Sparing Surgery and Radical Nephrectomy for Low-Stage Renal Cell Carcinoma Hit paper breakdown → | 2006 | 764 |
| 12 | Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysis Hit paper breakdown → | 2006 | 752 |
| 13 | A Prospective, Randomised EORTC Intergroup Phase 3 Study Comparing the Oncologic Outcome of Elective Nephron-Sparing Surgery and Radical Nephrectomy for Low-Stage Renal Cell Carcinoma Hit paper breakdown → | 2010 | 698 |
| 14 | Prognostic Factors for Survival in Adult Patients With Cerebral Low-Grade Glioma Hit paper breakdown → | 2002 | 657 |
| 15 | Cytoreductive Nephrectomy in Patients With Metastatic Renal Cancer: A Combined Analysis Hit paper breakdown → | 2004 | 605 |
| 16 | Adjuvant chemotherapy for localised resectable soft-tissue sarcoma of adults: meta-analysis of individual data Hit paper breakdown → | 1997 | 561 |
| 17 | European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: 2020 Update Hit paper breakdown → | 2020 | 561 |
| 18 | Recurrence and Progression of Disease in Non–Muscle-Invasive Bladder Cancer: From Epidemiology to Treatment Strategy Hit paper breakdown → | 2009 | 559 |
| 19 | EAU Guidelines on Non-Muscle-Invasive Urothelial Carcinoma of the Bladder Hit paper breakdown → | 2008 | 529 |
| 20 | Randomized Phase II/III Trial Assessing Gemcitabine/Carboplatin and Methotrexate/Carboplatin/Vinblastine in Patients With Advanced Urothelial Cancer Who Are Unfit for Cisplatin-Based Chemotherapy: EORTC Study 30986 Hit paper breakdown → | 2011 | 523 |
About Richard Sylvester
Richard Sylvester is a scholar working on Surgery, Pulmonary and Respiratory Medicine, Oncology, Urology and Cancer Research, having authored 369 papers that have together received 36.9k indexed citations. Recurring topics across this work include Bladder and Urothelial Cancer Treatments (158 papers), Urinary and Genital Oncology Studies (116 papers), Urological Disorders and Treatments (45 papers), Prostate Cancer Treatment and Research (35 papers), Renal cell carcinoma treatment (25 papers), Cancer Treatment and Pharmacology (24 papers), Breast Cancer Treatment Studies (24 papers) and Statistical Methods in Clinical Trials (23 papers). The work is most often cited by research in Urology (6.7k citations), Surgery (24.1k citations), Pulmonary and Respiratory Medicine (10.3k citations), Cancer Research (4.6k citations) and Oncology (8.3k citations). Richard Sylvester has collaborated with scholars based in Belgium, Netherlands and United Kingdom. Frequent co-authors include Adrian P.M. van der Meijden, Willem Oosterlinck, Marko Babjuk, Morgan Rouprêt, J. Alfred Witjes, Andreas Böhle, Bas W.G. van Rhijn, Shahrokh F. Shariat, Eero Kaasinen and Hendrik Van Poppel. Their work appears in journals such as European Urology, The Journal of Urology, Journal of Clinical Oncology, European Journal of Cancer and Controlled Clinical Trials.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.